{"transactions":[{"id":1860236,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2023-06-09T22:00:22.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as follows: (i) one third on the date of grant; (ii) one third on the first anniversary of the date of grant; and (iii) one third on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date."}],"balance_after":150000,"derivative":{"exercise_price":1.66,"expiration_date":"2028-06-07","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-23-020796","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315223020796/ownership.xml","form_type":"4"}},{"id":2541440,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-15T21:22:09.000Z","date":"2021-10-14","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest as follows: (i) 33% if the Company's market capitalization equals or exceeds $500,000,000 for at least 10 trading days during any 20 consecutive trading day period ending on or after December 15, 2021 (the \"Required Period\") and the fair market value (the \"FMV\") of the common stock equals or exceeds $5.00, subject to standard adjustments (the \"Minimum Share Value\") during such Required Period, (ii) 33% if the Company's market capitalization equals or exceeds $750,000,000 for the Required Period at the Minimum Share Value, and (iii) the remainder if the Company's market capitalization equals or exceeds $1,000,000,000 for the Required Period at the Minimum Share Value; provided that the RSUs shall vest immediately upon the occurrence of a change in control that values the Company's common stock at least $500,000,000, provided that the Reporting Person is providing services to the Company on the closing date of such change in control."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001493152-21-025609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221025609/ownership.xml","form_type":"4"}},{"id":2742876,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-21T21:55:11.000Z","date":"2021-04-16","kind":"exercise","acquired":false,"shares":131750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 131,750 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 11, 2020, the reporting person was granted 131,750 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":131750},"source":{"system":"sec-edgar","filing":"0001493152-21-009398","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009398/ownership.xml","form_type":"4"}},{"id":2742875,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T21:55:11.000Z","date":"2021-04-16","kind":"tax_withholding","acquired":false,"shares":46113,"price":4.94,"value":227798.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents 46,113 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 131,750 shares of RSUs on April 16, 2021."}],"balance_after":88238,"source":{"system":"sec-edgar","filing":"0001493152-21-009398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009398/ownership.xml","form_type":"4"}},{"id":2742874,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-21T21:55:11.000Z","date":"2021-04-16","kind":"exercise","acquired":true,"shares":131750,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the \"Company\")."}],"balance_after":134351,"source":{"system":"sec-edgar","filing":"0001493152-21-009398","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315221009398/ownership.xml","form_type":"4"}},{"id":3033055,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Chairman and President"}}],"security":"Restricted Stock Unit","published_at":"2020-09-11T22:22:00.000Z","date":"2020-09-11","kind":"grant","acquired":true,"shares":263500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\"). The Company may also elect to settle the vested RSUs for cash at its discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting Person was granted 263,500 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting Person was granted 263,500 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), with fifty percent (50%) of the RSUs to vest on the first anniversary of the date of grant, and the remaining fifty percent (50%) to vest on the second anniversary of the date of grant; provided that the RSUs shall vest immediately upon the occurrence of (i) a change in control, provided that the Reporting Person is employed by or providing services to the Company and its affiliates on the closing date of such change in control, (ii) the Reporting Person's termination of employment or service from the Company and its affiliates by reason of the Reporting Person's death or disability, or (iii) the Reporting Person's termination of employment or service by the Company without cause."}],"balance_after":263500,"derivative":{"underlying":"Common Stock","underlying_shares":263500},"source":{"system":"sec-edgar","filing":"0001493152-20-017668","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220017668/ownership.xml","form_type":"4"}},{"id":3322329,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Restricted Stock Units","published_at":"2020-01-04T00:11:04.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":5201,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On March 29, 2019, the reporting person was granted 5,201 RSUs of the Company, which vested on January 1, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5201},"source":{"system":"sec-edgar","filing":"0001493152-20-000166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220000166/ownership.xml","form_type":"4"}},{"id":3322328,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2020-01-04T00:11:04.000Z","date":"2020-01-01","kind":"exercise","acquired":true,"shares":5201,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\")."}],"balance_after":5201,"source":{"system":"sec-edgar","filing":"0001493152-20-000166","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315220000166/ownership.xml","form_type":"4"}},{"id":3567876,"issuer":{"id":7735,"kind":"organization","name":"Q/C TECHNOLOGIES, INC.","symbol":"QCLS"},"owners":[{"id":84585,"kind":"person","name":"Schreiber Christopher C","position":1,"cik":"0001750076","reported_name":"Schreiber Christopher C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-04-02T21:15:24.000Z","date":"2019-03-29","kind":"grant","acquired":true,"shares":124827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\"). The Company may also elect to settle the vested RSUs for cash at its discretion."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of common stock of Akers Biosciences, Inc. (the \"Company\"). The Company may also elect to settle the vested RSUs for cash at its discretion."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Reporting Person was granted 124,827 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), each of which shall vest on January 1, 2020; provided that the RSUs shall vest immediately upon a Change in Control. All capitalized but undefined terms have the meanings ascribed thereto by the Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Reporting Person was granted 124,827 RSUs under the Company's 2018 Equity Incentive Plan, as amended (the \"Plan\"), each of which shall vest on January 1, 2020; provided that the RSUs shall vest immediately upon a Change in Control. All capitalized but undefined terms have the meanings ascribed thereto by the Plan."}],"balance_after":124827,"derivative":{"exercise_date":"2020-01-01","underlying":"Common Stock","underlying_shares":124827},"source":{"system":"sec-edgar","filing":"0001493152-19-004746","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1321834/000149315219004746/ownership.xml","form_type":"4"}}]}